Leflunomide-500 mg

Catalog No.: C003B-385070
Mfr. No.: 14860-500
Mfr. Name: Cayman Chemical Company
Qty/UOM: 1
UOM: EA

Price: $916.61

List Price: $1,018.45

A prodrug for A-771726 that regulates T lymphocyte progression through the cell cycle by selectively inhibiting de novo pyrimidine synthesis used to slow the disease progression of rheumatoid arthritis and as an immunosuppressive agent to prevent

To proceed with your purchase, please call customer service at (732)447-1102.

Note: Hazmat items cannot be delivered to a residential address.

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Description
Specifications

A prodrug for A-771726 that regulates T lymphocyte progression through the cell cycle by selectively inhibiting de novo pyrimidine synthesis; used to slow the disease progression of rheumatoid arthritis and as an immunosuppressive agent to prevent rejection of transplant allografts and xenografts.

Shipping Information:

Hazmat Fee: $65.00 + applicable shipping charges are added after the order is placed.

More Information: https://cenmed.com/shipping-returns

UPC:: 51202501
Condition:: New
Availability:: 3 Days
Weight:: 1.00 Ounces
HazmatClass:: Yes
WeightUOM:: LB
MPN:: 14860-500
CAS:: 75706-12-6

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."